Health ❯ Side Effects
Medication Side Effects Injection Site Reactions Skin Reactions Clinical Study Findings
The FDA granted Fast Track status in February after strong midstage data highlighted its potential to address unmet needs in moderate-to-severe atopic dermatitis.
